NuGen

The companies will integrate Cambridge's TrueMethyl technology for oxidative bisulfite sequencing with NuGen's sequencing library preparation kits.

The new workflow, which was validated across three separate laboratories in New Jersey, is a critical step toward standardizing the use of RNA-seq in clinical genomics.

The firm is developing new applications for the technology, including one that will integrate targeted panels and copy number analysis into a single assay.

The partners will conduct a study to show the firms' technologies can help increase blood sample integrity and sequencing efficiency.

Nikon Research Corporation of America has been awarded

HandyLab has been awarded

IdentiGen recently announced the availability of a novel SNP genotyping assay chemistry called IdentiSNP that it claims confers major advantages over current commercial alternatives.

NuGen Technologies this week announced the release of the Ovation Human FFPE RNA-seq Multiplex System.

NuGen Technologies has launched its Ovation Human FFPE RNA-seq Multiplex System, which provides an end-to-end solution for strand-specific RNA-seq library prep from formalin-fixed paraffin-embedded tissue.

NEW YORK (GenomeWeb News) – Foundation Medicine's supply, service, and support agreement with Illumina inked in July is for five years and approximately $6.1 million, the Cambridge, Mass.-based firm said in an amended Form S-1 filed this week.

Pages

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.